Centro de Investigacao em Saude de Manhica Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT04370977
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Centro de Investigacao em Saude de Manhica

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 7